Estonia has rejected offers by pharmaceutical company Pfizer for its new coronavirus drug Paxlovid and is waiting for the outcome of the EU's next joint procurement. However, negotiations are stalling.
The Government Office and the Ministry of Social Affairs are working on a plan so that the coronavirus would not take Estonia by surprise again this fall.
The mortality rate of people over 60 years of age in the year following infection with the COVID-19 virus has increased significantly, it appears from the results of a recent study conducted by the University of Tartu focused on the effects of the COVID-19 pandemic on excess mortality.
Planned treatment will be suspended this week at East Tallinn Central Hospital due to the number of staff in isolation due to coronavirus, acting head of the Health Board Mari-Anne Härma said on Wednesday.
The government's scientific advisory council does not support the lifting of coronavirus restrictions, citing the rising infection rate, and believes coronavirus certificates will not be abolished on February 21.